Gregory Mayes

Gregory T.
Mayes was the founder of Engage Therapeutics, Inc., founded in 2017, where the titles held included President, Chief Executive Officer & Director from 2017 to 2020.
Current jobs include Director at Epilepsy Foundation since 2021, Director at Receptor Life Sciences, Inc. since 2020, Member of the New Jersey State Bar Association, Trustee at Kent Place School, Inc., and Member-Health Board for the City of Summit (New Jersey).
Former jobs include President, Chief Executive Officer & Director at Antios Therapeutics, Inc. from 2020 to 2022; President, Chief Executive Officer & Director at Reunion Neuroscience, Inc. from 2022 to 2026; Independent Director at OncoSec Medical, Inc. from 2018 to 2019; Director at Advaxis, Inc. from 2016 to 2017; Independent Director at AVEO Pharmaceuticals, Inc. from 2019 to 2023; Chief Compliance Officer & VP-General Counsel at ImClone LLC from 2004 to 2010; Secretary at Unigene Laboratories, Inc. from 2012 to 2013; Executive Vice President-Human Resources at Dendreon Corp.; Senior Counsel at AstraZeneca Pharmaceuticals LP from 2001 to 2004; and Member at BioNJ, Inc. Education includes an undergraduate degree from Syracuse University conferred in 1991 and a graduate degree from Temple University Beasley School of Law.